Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy.

Abstract

BACKGROUND The use of warfarin is growing for the prevention or treatment of cardiovascular or cerebrovascular diseases. The risk of haemorrhagic side effects is increased in patients taking warfarin. AIMS To evaluate risks related with withholding and resuming anticoagulation in patients with upper gastrointestinal bleeding (UGIB) while on warfarin… (More)
DOI: 10.1111/j.1742-1241.2011.02827.x

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.